dc.contributor
Institut Català de la Salut
dc.contributor
[Prieto Peres MF] Institute of Psychiatry, HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Department of Neurology, Hospital Albert Einstein, São Paulo, Brazil. [Sacco S] Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy. [Pozo-Rosich P] Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Tassorelli C] Headache Science & Neurorehabilitation Center, IRCCS C. Mondino Foundation, Pavia, Italy. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. [Ahmed F] Department of Neurosciences, Department of Neurology, Hull York Medical School, Hull, Kingston upon Hull, UK. [Burstein R] Department of Neurology and Department of Anaesthesia, Critical Care and Pain Medicine, BIDMC Comprehensive Headache Center, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Peres, Mario F P
dc.contributor.author
Ahmed, Fayyaz
dc.contributor.author
Burstein, Rami
dc.contributor.author
Sacco, Simona
dc.contributor.author
Pozo-Rosich, Patricia
dc.contributor.author
TASSORELLI, CRISTINA
dc.date.accessioned
2025-10-24T08:48:42Z
dc.date.available
2025-10-24T08:48:42Z
dc.date.issued
2025-02-12T13:56:44Z
dc.date.issued
2025-02-12T13:56:44Z
dc.identifier
Prieto Peres MF, Sacco S, Pozo-Rosich P, Tassorelli C, Ahmed F, Burstein R, et al. Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action. Cephalalgia. 2024 Aug;44(8):1–4.
dc.identifier
https://hdl.handle.net/11351/12593
dc.identifier
10.1177/03331024241267309
dc.identifier
001329235300007
dc.identifier.uri
http://hdl.handle.net/11351/12593
dc.description.abstract
Global burden of disease; Migraine; Neurological disorders
dc.description.abstract
Carga global de enfermedad; Migraña; Trastornos neurológicos
dc.description.abstract
Càrrega global de malaltia; Migranya; Trastorns neurològics
dc.description.abstract
The Global Burden of Disease (GBD) study is pivotal in shaping health policies by providing comprehensive data on mortality and disability. An updated GBD2021 analysis, published in Lancet Neurology on 14 March 2024, expands the scope of neurological disorders to include 37 conditions, revealing their significant impact on global health. Neurological disorders affect 3.4 billion people, or 43.1% of the global population, making them the leading cause of disability-adjusted life years (DALYs) in 2021, with an 18.2% increase since 1990. The top three causes of DALYs in this category are stroke, neonatal encephalopathy and migraine. Migraine, affecting 1.16 billion people, ranks first among children and adolescents and second among adults aged under 60 years. Despite its substantial impact, migraine often lacks proper attention because of its non-fatal nature, invisibility and historical neglect of neurological disorders. The International Headache Society calls for recognizing migraine as a serious medical condition, promoting research and integrating migraine management into public health strategies. Effective interventions include raising awareness, improving access to treatment, adding migraine to the epidemiological surveillance agenda and exploring new treatment strategies. A coordinated effort among stakeholders is essential to alleviate the burden of migraine on individuals and society.
dc.format
application/pdf
dc.publisher
SAGE Publications
dc.relation
Cephalalgia;44(8)
dc.relation
https://doi.org/10.1177/03331024241267309
dc.rights
Attribution-NonCommercial 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Migranya - Epidemiologia
dc.subject
Malalties cerebrovasculars - Epidemiologia
dc.subject
DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Headache Disorders::Headache Disorders, Primary::Migraine Disorders
dc.subject
Other subheadings::Other subheadings::Other subheadings::/epidemiology
dc.subject
DISEASES::Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders::Stroke
dc.subject
Other subheadings::Other subheadings::Other subheadings::/epidemiology
dc.subject
HEALTH CARE::Health Care Quality, Access, and Evaluation::Health Services Research::Global Burden of Disease
dc.subject
NAMED GROUPS::Persons::Age Groups::Child
dc.subject
NAMED GROUPS::Persons::Age Groups::Adult
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos con cefaleas::cefaleas primarias::trastornos migrañosos
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/epidemiología
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares::accidente cerebrovascular
dc.subject
Otros calificadores::Otros calificadores::Otros calificadores::/epidemiología
dc.subject
ATENCIÓN DE SALUD::calidad, acceso y evaluación de la atención sanitaria::investigación en servicios de salud::carga de morbimortalidad global
dc.subject
DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño
dc.subject
DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adulto
dc.title
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
